Frazier Management’s AnaptysBio ANAB Stock Holding History
Bought
Maintained
Sold
Other funds holding ANAB
EC
TCM
BC
FLSM
Frazier Management's ANAB Position: Q1 2022 in Review
Frazier Management sold out of AnaptysBio (ANAB) in Q1 2022, closing a stake of 899,700 shares — an estimated $31.3M sold.
Frazier Management first reported a position in ANAB in Q1 2017 and held it in 20 quarters. The position peaked at $384M in Q1 2018. 131 funds tracked by Wall St. Rank hold ANAB as of Q1 2022.
- Frazier Management reported no remaining AnaptysBio position as of Q1 2022 after selling out during the quarter.
- Frazier Management sold 899,700 AnaptysBio shares in Q1 2022, an estimated $31.3M.
- Frazier Management first reported a position in AnaptysBio in Q1 2017 and held it in 20 quarters.
- Frazier Management's AnaptysBio position peaked at $384M in Q1 2018.
- 131 funds tracked by Wall St. Rank held AnaptysBio as of Q1 2022.
Based on Frazier Management's 13F filing for Q1 2022, filed 13 May 2022.